Language selection

Search

2008-02-13 - Female - 18 Years old

302394

Adverse reaction report number 302394
Latest AER version number 0
Market authorization holder AER number SPV1200800207
Initial received date 2008-02-13
Latest received date 2008-02-13
Age 18 Years
Gender Female
Weight N/A
Type of report Spontaneous
Reporter type Pharmacist
Source of report MAH
Report outcome Not recovered/not resolved
Serious report? Yes

Reason for seriousness

Death
Disability
Cogenital anomaly
Life threateting
Hospitalization
Other medically important Yes

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XRCAPSULE, EXTENDED RELEASESuspectOral20 Milligram1 every 1 Day(s)6 Day(s)
EFFEXOR NOSNOT SPECIFIEDConcomitantUnknown
TETRACYCLINENOT SPECIFIEDConcomitantUnknown

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Discomfort
Fatigue
Heart rate increased
Somnolence
Date modified: